Retraction
Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling
Paper Information
Record ID:
40251
Author(s):
Journal:
Publication Date:
March 11, 2019
Retraction Date:
October 14, 2022
(3.1 years years ago)
Subjects:
Institutions:
- Department of Respiratory, Inflammation and Autoimmunity, MedImmune, Granta Park, Cambridge CB21 6GH, UK
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, UK
- Institute of Cancer Studies and Pharmaceutical Science, King’s College, 150 Stamford Street, London SE1 9NH, UK
Country:
🇬🇧 United KingdomArticle Type:
Publisher:
Oxford Academic
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations1
Post-Retraction(11.1%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
79
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Picking the best isoform
Dean Paes
Unknown Journal
Open Access
Published: Jan 2023
79 days after retraction
Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer
Deri Morgan, Kiersten L. Berggren, Colby Spiess et al. (9 authors)
Molecular Carcinogenesis
Open Access
Published: Sep 2021
23 citations
23 citations
385 days before retraction
Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
Haoming Chen, Ravi N. Padia, Tao Li et al. (7 authors)
npj Breast Cancer
Open Access
Published: Jul 2021
9 citations
9 citations
462 days before retraction
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
Dean Paes, Melissa Schepers, Ben Rombaut et al. (6 authors)
Pharmacological Reviews
Open Access
Published: Jul 2021
70 citations
70 citations
470 days before retraction
Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases
Martina Schmidt, Isabella Cattani‐Cavalieri, Francisco Núñez et al. (4 authors)
Current Opinion in Pharmacology
Open Access
Published: Apr 2020
25 citations
25 citations
926 days before retraction
Fibrin Breakdown Assay
Jiayue Ling, Connor M. Blair, George S. Baillie
BIO-PROTOCOL
Open Access
Published: Jan 2020
2 citations
2 citations
1017 days before retraction
Measuring cAMP Specific Phosphodiesterase Activity: A Two-step Radioassay
Connor M. Blair, Jiayue Ling, George S. Baillie
BIO-PROTOCOL
Open Access
Published: Jan 2020
1017 days before retraction
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes
Connor M. Blair, George S. Baillie
Biochemical Society Transactions
Open Access
Published: Sep 2019
22 citations
22 citations
1130 days before retraction
Quick Stats
Total Citations:
16
Years Since Retraction:
3.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025